Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Total deaths for women with HIV and their children are projected to be lower with dolutegravir-based (Tivicay) antiretroviral therapy (ART) versus efavirenz-based (Sustiva) ART, a model-based analysis found.

Published
05 April 2019
From
MedPage Today
EACS Standard of Care meeting report – Tackling HIV and co-infections in Europe: towards common standards

This is the full report from the EACS Standard of Care Meeting. It can also be read in three separate sections here.Eastern Europe continues to have

Published
29 March 2019
By
Gus Cairns
EACS takes steps towards a common, auditable European standard of care

The purpose of the European AIDS Clinical Society's (EACS) meeting in January in Bucharest, Romania was to devise consistent, auditable standards of care for HIV, co-infection and

Published
11 March 2019
By
Gus Cairns
Multiple benefits to scaling up universal test and treat in Africa

As well as the important findings of PopART, the largest HIV prevention trial ever conducted, this week’s Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle heard about

Published
08 March 2019
By
Roger Pebody
Mismatch between US infant feeding policies and the lived experience of HIV-positive women

US guidelines recommending that HIV-positive women feed their infants formula milk instead of breast milk create unique challenges for patients and healthcare providers alike, according to a mixed-methods

Published
26 February 2019
By
Krishen Samuel
Tackling HIV and hepatitis C in Europe: towards minimum standards

Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form

Published
08 February 2019
By
Gus Cairns
For Our Stable HIV Patients, Why Are We Still Sending All These Lab Tests So Often?

Do the guidelines for laboratory monitoring still make sense when our HIV treatments have become so safe and effective?

Published
29 January 2019
From
NEJM Journal Watch
Dolutegravir- why new does not automatically mean better

As has been previously reported by Spotlight, a new and exciting anti-retroviral, dolutegravir, is soon to become widely available in South Africa. Whilst its very real advantages have been extensively reported, the potential disadvantages have received relatively little attention.

Published
25 January 2019
From
Spotlight
HIV care is threatened by proposed changes to Medicare Part D

Optimal HIV care includes early and uninterrupted access to effective antiretroviral medications. Proposed changes to Medicare Part D threatens that.

Published
25 January 2019
From
STAT
Atripla or efavirenz plus Truvada failed one in 16 people in first year

Although analyses of the failure rate of ART have been conducted before, a new analysis is the first to compute these rates for a single-drug regimen

Published
21 January 2019
By
Gus Cairns
← First12345...39Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.